UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S

Diabetes care, 2003-06, Vol.26 (6), p.1790-1795

2003

Link zum Volltext

Verfügbarkeit prüfen

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

Infectious diseases and therapy, 2023-08, Vol.12 (8), p.2117-2133

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses

Infectious diseases and therapy, 2024-04, Vol.13 (4), p.875-889

2024

Link zum Volltext

Verfügbarkeit prüfen

Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study

Infectious diseases and therapy, 2024-04, Vol.13 (4), p.891-906

2024

Link zum Volltext

Verfügbarkeit prüfen

Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study

Infectious diseases and therapy, 2020-03, Vol.9 (1), p.41-52

2020

Link zum Volltext

Verfügbarkeit prüfen

Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain

Current medical research and opinion, 2005-10, Vol.21 (10), p.1617-1629

2005

Link zum Volltext

Verfügbarkeit prüfen

Real-World Experience with Dolutegravir-Based Two-Drug Regimens

AIDS research and treatment, 2020, Vol.2020, p.5923256-8

2020

Link zum Volltext

Verfügbarkeit prüfen

The association between diabetes related medical costs and glycemic control: a retrospective analysis

Cost effectiveness and resource allocation, 2006-01, Vol.4 (1), p.1-1, Article 1

2006

Link zum Volltext

Verfügbarkeit prüfen

Optimization of BMD Measurements to Identify High Risk Groups for Treatment—A Test Analysis

Journal of bone and mineral research, 2004-06, Vol.19 (6), p.906-913

2004

Link zum Volltext

Verfügbarkeit prüfen

Predicted Costs and Outcomes From Reduced Vibration Detection in People With Diabetes in the U.S

Diabetes care, 2003-08, Vol.26 (8), p.2305-2310

2003

Link zum Volltext

Verfügbarkeit prüfen

A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue Sarcoma

Sarcoma, 2016, Vol.2016, p.3597609-13

2016

Link zum Volltext

Verfügbarkeit prüfen

The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy

Diabetes technology & therapeutics, 2005-06, Vol.7 (3), p.497-508

2005

Link zum Volltext

Verfügbarkeit prüfen

The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy

Health and quality of life outcomes, 2008-11, Vol.6 (1), p.95-95

2008

Link zum Volltext

Verfügbarkeit prüfen

Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: An Adjunctive Treatment for Type 2 Diabetes Mellitus

Value in health, 2008, Vol.11 (1), p.22-33

2008

Link zum Volltext

Verfügbarkeit prüfen

The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women

Journal of rheumatology, 2003-07, Vol.30 (7), p.1579

2003

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States

Journal of managed care & specialty pharmacy, 2021-07, Vol.27 (7), p.891

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics and treatment patterns among US patients with HIV

The American journal of managed care, 2019-12, Vol.25 (12), p.580-586

2019

Link zum Volltext

Verfügbarkeit prüfen

Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic Review

Journal of managed care & specialty pharmacy, 2020-02, Vol.26 (2), p.104

2020

Link zum Volltext

Verfügbarkeit prüfen

1544. HIV Following Oral Pre-Exposure Prophylaxis (PrEP) Initiation

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Link zum Volltext

Verfügbarkeit prüfen

1279. Real World Treatment Experience of Treatment-Naïve People with HIV who Initiated Treatment with Single Tablet Dolutegravir/Lamivudine in a Test and Treat setting in the US

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Link zum Volltext

Verfügbarkeit prüfen

1278. Real World Treatment Experience of Single Tablet Dolutegravir/Lamivudine in Those Naïve to Treatment with Baseline Viral Loads ≥ 100,000 copies/mL in the US

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Link zum Volltext

Verfügbarkeit prüfen

Characteristics Associated with Response to Antiretroviral Therapy (ART) among People Living with Human Immunodeficiency Virus (PLWH)

Journal of the National Medical Association, 2020-10, Vol.112 (5), p.S25-S25

2020

Link zum Volltext

Verfügbarkeit prüfen

943. Older Gay Black Men Living with HIV Report Higher Quality of Life than Older Gay White Men, Despite Facing Additional Burdens

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S504-S504

2020

Link zum Volltext

Verfügbarkeit prüfen

853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S516-S517

2021

Link zum Volltext

Verfügbarkeit prüfen

1843. Exploring Cisgender Women's HIV Pre-Exposure Prophylaxis (PrEP) Needs and Preferences Across Settings: the Roles of Social-Structural Factors

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(55)
Tagungsberichte
(3)

Sprache

Englisch
(58)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(23)
Humans
(16)
Abstracts
(6)
Hiv
(6)
Infectious Diseases
(6)
Internal Medicine
(6)
Aged
(5)
Analysis
(5)
Antiretroviral Drugs
(5)
Clinical Trials
(5)
Diabetes
(5)
Diabetes Mellitus, Type 2 - Economics
(5)
Female
(5)
Health Care Sciences & Services
(5)
Medicine
(5)
Medicine & Public Health
(5)
Middle Aged
(5)
United States
(5)
Antiviral Agents
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens

Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses

Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study

Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study

Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain

Real-World Experience with Dolutegravir-Based Two-Drug Regimens

The association between diabetes related medical costs and glycemic control: a retrospective analysis

Optimization of BMD Measurements to Identify High Risk Groups for Treatment—A Test Analysis

Predicted Costs and Outcomes From Reduced Vibration Detection in People With Diabetes in the U.S

A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue Sarcoma

The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy

The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy

Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: An Adjunctive Treatment for Type 2 Diabetes Mellitus

The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women

Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States

Clinical characteristics and treatment patterns among US patients with HIV

Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic Review

1544. HIV Following Oral Pre-Exposure Prophylaxis (PrEP) Initiation

1279. Real World Treatment Experience of Treatment-Naïve People with HIV who Initiated Treatment with Single Tablet Dolutegravir/Lamivudine in a Test and Treat setting in the US

1278. Real World Treatment Experience of Single Tablet Dolutegravir/Lamivudine in Those Naïve to Treatment with Baseline Viral Loads ≥ 100,000 copies/mL in the US

Characteristics Associated with Response to Antiretroviral Therapy (ART) among People Living with Human Immunodeficiency Virus (PLWH)

943. Older Gay Black Men Living with HIV Report Higher Quality of Life than Older Gay White Men, Despite Facing Additional Burdens

853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US

1843. Exploring Cisgender Women's HIV Pre-Exposure Prophylaxis (PrEP) Needs and Preferences Across Settings: the Roles of Social-Structural Factors

Aktive Filter

Suchergebnisse filtern